ROBERT HOFFMAN Insider Trading $HRTX HERON THERAPEUTICS, INC. /DE/
Get free email notifications about insider trading for ROBERT HOFFMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HOFFMAN. ROBERT HOFFMAN is CFO & SVP, Finance in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and CFO & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and SVP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in CombiMatrix Corp ($CBMX) and CHIEF FINANCIAL OFFICER in INNOVUS PHARMACEUTICALS, INC. ($INNV) and Director in Kura Oncology, Inc. ($KURA) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Director in Aravive, Inc. ($VSAR).
ROBERT HOFFMAN in HERON THERAPEUTICS, INC. /DE/
Trading Symbol: HRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN: CFO & SVP, Finance
Holdings: 1,280 shares
Latest Transaction: Dec 23 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT HOFFMAN in HERON THERAPEUTICS, INC. /DE/
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, ARNA, CBMX, HRTX, INNV, KTRA, KURA, MBVX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 25.02 | 100,000 | 2,502,000 | 100,000 | |
Dec 18 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 24.97 | 71,000 | 1,772,870 | 71,000 | |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | M | 15.30 | 30,000 | 459,000 | 100,000 | |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Sell | S | 38.80 | 1,060 | 41,123 | 1,280 | 2.3 K to 1.3 K (-45.30 %) |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Sell | S | 38.15 | 28,940 | 1,104,107 | 2,340 | 31.3 K to 2.3 K (-92.52 %) |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | M | 15.30 | 30,000 | 459,000 | 31,280 | 1.3 K to 31.3 K (+2,343.75 %) |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | J | 13.22 | 744 | 9,834 | 1,280 | 536 to 1.3 K (+138.81 %) |
Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 17.00 | 56,667 | 963,339 | 56,667 | |
Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | J | 13.05 | 536 | 6,993 | 536 | 0 to 536 |
Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 15.30 | 130,000 | 1,989,000 | 130,000 |
Page: 1